Aurora kinase inhibitor 3, Purity ≥98%

Cat. No.: X23-10-ZQ460

Aurora kinase inhibitor 3, Purity ≥98%

Synonym: Aurora Kinase Inhibitor III; 879127-16-9; Aurora Kinase Inhibitor 3; 2np8; AKI-7169; N-(3-((4-((3-(Trifluoromethyl)phenyl)amino)pyrimidin-2-yl)amino)phenyl)cyclopropanecarboxamide; N-{3-[(4-{[3-(Trifluoromethyl)phenyl]amino}pyrimidin-2-yl)amino]phenyl}cyclopropanecarboxamide; Aurora kinase inhibitor

  • MDL: MFCD09265250
  • CAS Number: 879127-16-9
  • Compound CID: 9549303
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Aurora kinase inhibitor 3, soluble in DMSO and ethanol and insoluble in water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A.
Molecular Weight
413.4
Molecular Formula
C21H18F3N5O
Targets
Aurora A: 42 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 82 mg/mL (198.35 mM); Water: Insoluble; Ethanol: 5 mg/mL (12.09 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Aurora kinase inhibitor 3 can be utilized to analyze the impact of Aurora kinase inhibition on cancer cell growth.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.